Coding and traceability for cells, tissues and organs for transplantation.
Modern transplantation of cells, tissues and organs has been practiced within the last century achieving both life saving and enhancing results. Associated risks have been recognized including infectious disease transmission, malignancy, immune mediated disease and graft failure. This has resulted in establishment of government regulation, professional standard setting and establishment of vigilance and surveillance systems for early detection and prevention and to improve patient safety. The increased transportation of grafts across national boundaries has made traceability difficult and sometimes impossible. Experience during the first Gulf War with mis-identification of blood units coming from multiple countries without standardized coding and labeling has led international organizations to develop standardized nomenclature and coding for blood. Following this example, cell therapy and tissue transplant practitioners have also moved to standardization of coding systems. Establishment of an international coding system has progressed rapidly and implementation for blood has demonstrated multiple advantages. WHO has held two global consultations on human cells and tissues for transplantation, which recognized the global circulation of cells and tissues and growing commercialization and the need for means of coding to identify tissues and cells used in transplantation, are essential for full traceability. There is currently a wide diversity in the identification and coding of tissue and cell products. For tissues, with a few exceptions, product terminology has not been standardized even at the national level. Progress has been made in blood and cell therapies with a slow and steady trend towards implementation of the international code ISBT 128. Across all fields, there are now 3,700 licensed facilities in 66 countries. Efforts are necessary to encourage the introduction of a standardized international coding system for donation identification numbers, such as ISBT 128, for all donated biologic products.
Strong
D Michael
DM
Department of Orthopaedics and Sports Medicine, University of Washington School of Medicine, Seattle, WA, USA. dmichaelstrong@mac.com
Shinozaki
Naoshi
N
D001803:Blood Transfusion / Q000592:standards*; D001330:Electronic Data Processing / Q000592:standards*; D017408:Guidelines as Topic; D006801:Humans; D008499:Medical Records / Q000592:standards; D016377:Organ Transplantation / Q000592:standards; D012306:Risk; D014015:Tissue Banks; D014019:Tissue Donors; D016378:Tissue Transplantation / Q000592:standards; D009927:Tissue and Organ Procurement / Q000592:standards*; D019737:Transplants / Q000592:standards*; D014944:World Health Organization
Bone Marrow Transplant. 2007 Dec;40(11):1075-83
17906708
Transplantation. 2005 Mar 27;79(6):635
15785363
Vox Sang. 1980 Sep;40(3):175-80
7248021
Clin Exp Ophthalmol. 2005 Dec;33(6):642-57
16402960
Ann Intern Med. 2005 Nov 1;143(9):648-54
16263887
Ann Surg. 1947 Dec;126(6):932-46
18898655
Vox Sang. 1981 Mar;40(3):144-55
7245707
N Engl J Med. 1957 Sep 12;257(11):491-6
13464965
Cell Tissue Bank. 2007;8(4):267-86
17440834
Cell Tissue Bank. 2000;1(1):9-16
15256965
J Drugs Dermatol. 2002 Dec;1(3):298-301
12851989
Arch Ophthalmol. 2008 Feb;126(2):235-9
18268215
J Am Med Assoc. 1948 Jun 12;137(7):588-94
18864345
Liver Transpl. 2008 Nov;14(11):1603-8
18975294
Fed Regist. 2005 Jun 3;70(106):32619-32620
27737139
N Engl J Med. 2007 Dec 20;357(25):2601-14
18094380
Vox Sang. 2010 Jan;98(1):85-6
20017864
J Am Acad Orthop Surg. 2008 Oct;16(10):559-65
18832599
Trans Am Clin Climatol Assoc. 1955-1956;67:167-73
13360847
Am J Transplant. 2009 Aug;9(8):1929-35
19538493
Clin Orthop Relat Res. 1988 Jan;(226):292-8
3275515
Cell Tissue Bank. 2009 Aug;10(3):271-80
19016348